Antithrombin-III for Patients With Hepatic Veno-occlusive Diseases Following Hematopoietic Stem Cell Transplantation

NCT01886248 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Hepatic Veno-Occlusive Disease

Interventions

DRUG: Freeze-dried Concentrated Human Antithrombin Ⅲ 500 IU

Sponsor

Seoul National University Hospital